Market Value1,453,819,000
Total Holdings60
File Date2014-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VENTRUS BIOSCIENCES INC / (922822101)
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
449575AB5 / Igi Laboratories Inc Bond
SAVA / Cassava Sciences, Inc.
ATRC / AtriCure, Inc.
TRGT / Targacept
RIGL / Rigel Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
SGNT / Sagent Pharmaceuticals, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
LBMH / Liberator Medical Holdings, Inc.
ACRX / Talphera, Inc.
STJ / St. Jude Medical, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
TXMD / TherapeuticsMD, Inc.
MOH / Molina Healthcare, Inc.
ANTH / Anthera Pharmaceuticals, Inc.
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
WINT / Windtree Therapeutics, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
AVDL / Avadel Pharmaceuticals plc
MLNT / Melinta Therapeutics, Inc.
INFI / Infinity Pharmaceuticals Inc.
NXTM / NxStage Medical, Inc.
EBS / Emergent BioSolutions Inc.
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
032420101 / Anacor Pharmaceuticals, Inc.
NPSP / NPS Pharmaceuticals Inc
POZN / Pozen, Inc.
NVLN / NOVELION THERAPEUTICS INC.
ZGNX / Zogenix Inc
ATRS / Antares Pharma Inc
US2538277037 / Digirad Corp.
ALBO / Albireo Pharma Inc
EPZM / Epizyme Inc
BDSI / Biodelivery Sciences International
NTUS / Natus Medical Inc
DXTR / Dextera Surgical Inc.
ELOS / Syneron Medical Ltd.
IPXL / Impax Laboratories, Inc.
CUTR / Cutera, Inc.
ISEE / IVERIC bio Inc
CASM / CAS Medical Systems, Inc.
HZNP / Horizon Therapeutics Plc
IDRA / Idera Pharmaceuticals, Inc.
XNCR / Xencor, Inc.
ANGO / AngioDynamics, Inc.
AUXL / Auxilium Pharmaceuticals Inc
LCI / Lannett Co., Inc.
SLTM / Solta Medical Inc
DRTX / Durata Therapeutics Inc
WMGIZ / Wright Medical Group N.V.
DSCI / Derma Sciences, Inc.
MRTX / Mirati Therapeutics, Inc.
RAD / Rite Aid Corp.
SRPT / Sarepta Therapeutics, Inc.
ASRT / Assertio Holdings, Inc.
AERI / Aerie Pharmaceuticals Inc
DRRX / DURECT Corporation